| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses
|
Talaat, Adel M.
|
|
2001
|
20 |
3-4 |
p. 538-544
7 p.
|
artikel
|
| 2 |
Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes
|
Nanan, Ralph
|
|
2001
|
20 |
3-4 |
p. 498-504
7 p.
|
artikel
|
| 3 |
Ad Hoc Working Group on acellular pertussis vaccines, World Health Organisation, Geneva, 27–28 July 2000
|
Corbel, M.J.
|
|
2001
|
20 |
3-4 |
p. 288-291
4 p.
|
artikel
|
| 4 |
Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination
|
Marth, E
|
|
2001
|
20 |
3-4 |
p. 532-537
6 p.
|
artikel
|
| 5 |
ANNOUNCEMENT
|
|
|
2001
|
20 |
3-4 |
p. 636-
1 p.
|
artikel
|
| 6 |
An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice
|
Niethammer, Andreas G
|
|
2001
|
20 |
3-4 |
p. 421-429
9 p.
|
artikel
|
| 7 |
A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin–neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains
|
Babai, Ilan
|
|
2001
|
20 |
3-4 |
p. 505-515
11 p.
|
artikel
|
| 8 |
Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice
|
Ramı́rez, José Robinson
|
|
2001
|
20 |
3-4 |
p. 455-461
7 p.
|
artikel
|
| 9 |
A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC)
|
Stratford, Richard
|
|
2001
|
20 |
3-4 |
p. 516-525
10 p.
|
artikel
|
| 10 |
BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria–tetanus antigens
|
Garly, May-Lill
|
|
2001
|
20 |
3-4 |
p. 468-474
7 p.
|
artikel
|
| 11 |
Birth of MHC-defined rhesus monkeys produced by assisted reproductive technology
|
Schramm, R.Dee
|
|
2001
|
20 |
3-4 |
p. 603-607
5 p.
|
artikel
|
| 12 |
Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers
|
Ölander, Rose-Marie
|
|
2001
|
20 |
3-4 |
p. 336-341
6 p.
|
artikel
|
| 13 |
Circumvention of MHC class II restriction by genetic immunization
|
Schuler, Kilian
|
|
2001
|
20 |
3-4 |
p. 630-634
5 p.
|
artikel
|
| 14 |
Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP119 expressed in distinct bacterial vectors
|
Cunha, Maristela G
|
|
2001
|
20 |
3-4 |
p. 385-396
12 p.
|
artikel
|
| 15 |
Covalent complexes of antigen and α2-macroglobulin: evidence for dramatically-increased immunogenicity
|
Cianciolo, George J
|
|
2001
|
20 |
3-4 |
p. 554-562
9 p.
|
artikel
|
| 16 |
Developing Country Vaccine Manufacturers Network (DCVMN), 26–27 April 2001, Bandung, Indonesia
|
Henriks, J.
|
|
2001
|
20 |
3-4 |
p. 285-287
3 p.
|
artikel
|
| 17 |
DNA-mediated vaccination against infectious bursal disease in chickens
|
Chang, Hua Chen
|
|
2001
|
20 |
3-4 |
p. 328-335
8 p.
|
artikel
|
| 18 |
DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice
|
Chlichlia, Katerina
|
|
2001
|
20 |
3-4 |
p. 439-447
9 p.
|
artikel
|
| 19 |
Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals
|
Bolmstedt, Anders
|
|
2001
|
20 |
3-4 |
p. 397-405
9 p.
|
artikel
|
| 20 |
Epidemiology of primary varicella hospitalizations in Spain
|
Gil, Angel
|
|
2001
|
20 |
3-4 |
p. 295-298
4 p.
|
artikel
|
| 21 |
Erratum to “Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin” [Vaccine 19 (2001) 3241–3247]
|
Fellows, P.F.
|
|
2001
|
20 |
3-4 |
p. 635-
1 p.
|
artikel
|
| 22 |
Identification of an association between HLA class II alleles and low antibody levels after measles immunization
|
Poland, Gregory A.
|
|
2001
|
20 |
3-4 |
p. 430-438
9 p.
|
artikel
|
| 23 |
Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice
|
Da’dara, Akram A
|
|
2001
|
20 |
3-4 |
p. 359-369
11 p.
|
artikel
|
| 24 |
Inactivation of viruses by aziridines
|
Brown, F.
|
|
2001
|
20 |
3-4 |
p. 322-327
6 p.
|
artikel
|
| 25 |
Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope
|
Shams, Homayoun
|
|
2001
|
20 |
3-4 |
p. 577-585
9 p.
|
artikel
|
| 26 |
Interleukin-2 fusion protein with anti-CD3 single-chain Fv (sFv) selectively protects T cells from dexamethasone-induced apoptosis
|
Kim, Eui J
|
|
2001
|
20 |
3-4 |
p. 608-615
8 p.
|
artikel
|
| 27 |
Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China
|
Shi, Fuhui
|
|
2001
|
20 |
3-4 |
p. 462-467
6 p.
|
artikel
|
| 28 |
Laboratory testing of whole cell pertussis vaccine: a WHO proficiency study using the Kendrick test
|
Xing, D
|
|
2001
|
20 |
3-4 |
p. 342-351
10 p.
|
artikel
|
| 29 |
Lack of contact transmission of recombinant Marek’s disease virus type 1 expressing the fusion protein of Newcastle disease virus
|
Okamura, H
|
|
2001
|
20 |
3-4 |
p. 483-489
7 p.
|
artikel
|
| 30 |
Large scale safety study of a liquid hexavalent vaccine (D-T-acP–IPV–PRP∼T–HBs) administered at 2, 4, 6 and 12–14 months of age
|
Liese, J.G.
|
|
2001
|
20 |
3-4 |
p. 448-454
7 p.
|
artikel
|
| 31 |
Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOMATRIX®
|
Windon, R.G.
|
|
2001
|
20 |
3-4 |
p. 490-497
8 p.
|
artikel
|
| 32 |
Marburg virus vaccines: comparing classical and new approaches
|
Hevey, M.
|
|
2001
|
20 |
3-4 |
p. 586-593
8 p.
|
artikel
|
| 33 |
Measles vaccine immunogenicity and antibody persistence in 12- vs. 15-month-old infants
|
Arya, Subhash C.
|
|
2001
|
20 |
3-4 |
p. 294-
1 p.
|
artikel
|
| 34 |
Modeling the economic benefits of an AIDS vaccine
|
Bishai, David
|
|
2001
|
20 |
3-4 |
p. 526-531
6 p.
|
artikel
|
| 35 |
Mucosal and systemic HIV-1 Env-specific CD8+ T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector
|
Shata, Mohamed T.
|
|
2001
|
20 |
3-4 |
p. 623-629
7 p.
|
artikel
|
| 36 |
Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity
|
Singh, Manmohan
|
|
2001
|
20 |
3-4 |
p. 594-602
9 p.
|
artikel
|
| 37 |
Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice
|
Hart, Mary Kate
|
|
2001
|
20 |
3-4 |
p. 616-622
7 p.
|
artikel
|
| 38 |
Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen
|
Paoletti, Lawrence C
|
|
2001
|
20 |
3-4 |
p. 370-376
7 p.
|
artikel
|
| 39 |
Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines
|
Andre, F.E.
|
|
2001
|
20 |
3-4 |
p. 292-293
2 p.
|
artikel
|
| 40 |
Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults
|
Feikin, Daniel R.
|
|
2001
|
20 |
3-4 |
p. 545-553
9 p.
|
artikel
|
| 41 |
Rational development of prophylactic HIV vaccines based on structural and regulatory proteins
|
Mooij, Petra
|
|
2001
|
20 |
3-4 |
p. 304-321
18 p.
|
artikel
|
| 42 |
Rectal immunization with antigen-containing microspheres induces stronger Th2 responses than oral immunization: a new method for vaccination
|
Nakase, Hiroshi
|
|
2001
|
20 |
3-4 |
p. 377-384
8 p.
|
artikel
|
| 43 |
Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine
|
de Kleijn, Ester
|
|
2001
|
20 |
3-4 |
p. 352-358
7 p.
|
artikel
|
| 44 |
T cell responses to major membrane protein II (MMP II) of Mycobacterium leprae are restricted by HLA-DR molecules in patients with leprosy
|
Ohyama, Hideki
|
|
2001
|
20 |
3-4 |
p. 475-482
8 p.
|
artikel
|
| 45 |
Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland
|
Gzyl, Anna
|
|
2001
|
20 |
3-4 |
p. 299-303
5 p.
|
artikel
|
| 46 |
The role of the individual amino acids of a GnRH-tandem-dimer peptide used as an antigen for immunocastration of male piglets determined with systematic alanine replacements
|
Turkstra, J.A.
|
|
2001
|
20 |
3-4 |
p. 406-412
7 p.
|
artikel
|
| 47 |
Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy
|
Koesling, Jan
|
|
2001
|
20 |
3-4 |
p. 413-420
8 p.
|
artikel
|
| 48 |
Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates
|
Lee, Sandra A
|
|
2001
|
20 |
3-4 |
p. 563-576
14 p.
|
artikel
|
Tijdschrift beschrijving